Yi-Lin Yang

Principal Scientist at Ultragenyx Pharmaceutical

Yi-Lin Yang is a Senior Scientist at Ultragenyx since July 2021, previously holding the position of Scientist II at Vinta Bio and Excel BioPharm, contributing to bispecific T cell engager antibody development for immunotherapy, T cell functional assays, and antibody engineering. Yi-Lin Yang served as an Assistant Adjunct Professor at the University of California, San Francisco, focusing on small molecular drug discovery and preclinical efficacy of novel therapeutics, with a total of 17 peer-reviewed journal publications. Earlier roles included postdoctoral research at NCIRE, research assistant positions at Tufts University and OHSU, and volunteer research assistance at Kaohsiung Medical University. Yi-Lin Yang holds a Ph.D. in Comparative Biomedical Sciences from Tufts University, an M.S. in Biochemistry and Molecular Biology from Oregon Health & Science University, and a B.S. in Biology from Kaohsiung Medical University.

Location

San Francisco, United States

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Ultragenyx Pharmaceutical

11 followers

Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.


Industries

Employees

501-1,000

Links